TITLE

Lamifiban: A Viewpoint by David J. Moliterno

AUTHOR(S)
Moliterno, D.J.
PUB. DATE
February 1999
SOURCE
Drugs;Feb1999, Vol. 57 Issue 2, p222
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Comments on lamifiban, one of the most potent members of the small-molecule class of IIb/IIIa inhibitors developed for intravenous administration. Kinetics which make lamifiban's antiplatelet effect highly dependent on renal function; Antiplatelet effect of peptidomimetrics; Benefits from lamifiban.
ACCESSION #
9592954

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics